References

1.	Granger DK. Enteric-coated mycophenolate sodium: results of two pivotal global multicenter trials. Transplant Proc. 2001;33:3241-3244.
2.	Budde K, Curtis J, Knoll G, et al. Enteric-coated mycophenolate sodium can be administered in maintenance renal transplant patients: results of a 1-year study. Am J Transplant. 2004;4:237-243.
3.	myfortic® (mycophenolic acid) delayed-release tablets Package Insert. East Hanover, NJ: Novartis Pharmaceuticals Corporation; February 2004.
4.	Salvadori M. Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients. Transplant Proc. 2001;33:3245-3247.
5.	Salvadori M, Holzer H, De Mattos A, et al. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant. 2004;4:231-236.

Click here for full prescribing information, which includes contraindications, warnings, precautions, and adverse events.

Back to top